AVPT vs CLBT Stock Comparison
AVPT currently leads CLBT in this stock comparison, with AIQ scores of 70 vs 59. The clearest difference is momentum, while CLBT has the stronger value profile.
What is the main difference between AVPT and CLBT?
AVPT leads the current stock comparison as AvePoint, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
AvePoint, Inc. vs Cellebrite DI Ltd.
AVPT leads
AVPT leads by 11 AIQ points, primarily on Momentum and Risk Resilience, but the lead has narrowed from 16 points over 30 sessions.
Fragile: 3 of 5 evidence groups support AVPT, its lead is narrowing, and its current signal state is conflicted.
AvePoint, Inc.
Cellebrite DI Ltd.
The Algovestiq AIQ Score currently favors AVPT over CLBT, 70 versus 59 as of Nov 15, 2026. AVPT's advantage is driven primarily by stronger momentum and risk resilience, while CLBT holds the stronger value profile. AVPT also shows the stronger technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor AVPT today, and the comparison is rated Fragile on stability: the leader's advantage has been narrowing. AVPT lead: Weakening — the AIQ differential moved from 16 to 11 points over 30 sessions.
Compare AvePoint, Inc. and Cellebrite DI Ltd. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare AVPT and CLBT against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum91 vs 54AVPT +37
- Risk Resilience67 vs 50AVPT +17
- Value43 vs 56CLBT +13
- Quality65 vs 72CLBT +7
3 of 5 evidence groups favor AVPT. AVPT’s edge is concentrated in momentum and risk resilience; CLBT keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 6 active signals are unchanged.
Largest factor move: Momentum +3
New signals
- Accumulation Pattern — bullish, volume, medium horizon (2.48x)
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.3%)
- Volume Surge - Bullish — bullish, volume, short horizon (2.48x)
AVPT's lead narrowed by 2 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — AVPT and CLBT both carry a full feed there.
The central trade-off
AVPT (AvePoint, Inc.): the stronger current systematic profile, led by momentum and risk resilience.
CLBT (Cellebrite DI Ltd.): the counter-case, on value, quality, fundamentals — but at materially higher volatility, 61.1% against 35.8%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
AVPTAVPT on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
CLBTCLBT on combined revenue and EPS growth.
Value
CLBTCLBT on the peer-relative Value factor, by 13 points.
Momentum
AVPTAVPT on the Momentum factor, by 37 points.
Lower downside
AVPTAVPT on Risk Resilience, by 17 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AVPT | CLBT | Note |
|---|---|---|---|
| Implied upside to target | +12.4% | — | Level |
| Target dispersion | +16.1% | — | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 18 | 8 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor AVPT. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | AVPT | 70 vs 59 |
| Fundamentals | CLBT | revenue growth 5.3% vs 13.6%; EPS growth -30.8% vs 3.3%; TTM ROE 4.1% vs 4.6%; gross margin 72.9% vs 82.3%; operating margin 10% vs 12% |
| Valuation | CLBT | Value 43 vs 56 |
| Technicals | AVPT | Price vs 50-day 11.5% vs -0.6%; vs 200-day 36.9% vs -12.6% |
| Risk Resilience | AVPT | Risk Resilience 67 vs 50 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVPT and CLBT and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 11 points.
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AVPT.
How the comparison changed
120 daily snapshots · May 27 – Nov 13AVPT lead: Weakening — the AIQ differential moved from 16 to 11 points over 30 sessions.
- Today
- AVPT +11
- 70 vs 59
- 7 sessions ago
- AVPT +15
- 69 vs 54
- 30 sessions ago
- AVPT +16
- 68 vs 52
- 90 sessions ago
- AVPT +9
- 64 vs 55
The lead changed hands once in this window, most recently on Jun 9 when AVPT moved ahead of CLBT.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 2 bearish / 1 neutral, conflicted
Only AVPT
- Golden Cross Active — bullish, trend, long horizon (22.77%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.29x)
- Uptrend Structure Active — bullish, trend, long horizon
3 bullish / 3 bearish / 1 neutral, conflicted
Only CLBT
- Death Cross Active — bearish, trend, long horizon (13.77%)
- Accumulation Pattern — bullish, volume, medium horizon (2.48x)
- Downtrend Structure Active — bearish, trend, long horizon
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.3%)
- Volume Surge - Bullish — bullish, volume, short horizon (2.48x)
Both carry 2 more signals that do not separate them: ATR Expansion - Breakout Mode, MACD Histogram Expanding Bearish.
AVPT leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.04%, AIQ 0 points).
Price and the AIQ Score both moved up over the latest session (price +5.88%, AIQ +2 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1CLBT closes the Momentum gap — currently 37 points behind, the largest single contributor to AVPT's edge.
- 2CLBT's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3AVPT's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once.
- 4The narrowing continues — the lead has already given back 5 points over 30 sessions, and a further 11-point move would eliminate AVPT's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
CLBT leads on balance| Metric | AVPT | CLBT |
|---|---|---|
| Revenue growth (YoY) | 5.3% | 13.6% |
| EPS growth (YoY) | -30.8% | 3.3% |
| Gross margin | 72.9% | 82.3% |
| Operating margin | 10% | 12% |
| Return on equity (TTM) | 4.1% | 4.6% |
| Debt to equity | 0.04 | 0.04 |
Performance
AVPT leads 6 of 6 windows| Metric | AVPT | CLBT |
|---|---|---|
| 1 week (5 sessions) | 0% | -7.4% |
| 1 month (20 sessions) | 15.5% | 4.5% |
| 3 months (63 sessions) | 24.9% | 10.4% |
| 6 months (126 sessions) | 66.7% | -11.2% |
| Year to date | 19.2% | -36.1% |
| 1 year (252 sessions) | 25.3% | -27.8% |
Technicals
AVPT has the stronger structure| Metric | AVPT | CLBT |
|---|---|---|
| RSI (14) | 57.3 | 45.2 |
| ADX (14) | 38.1 | 15.8 |
| Price vs 50-day | 11.5% | -0.6% |
| Price vs 200-day | 36.9% | -12.6% |
| Volatility (1M, annualized) | 35.8% | 61.1% |
Risk
AVPT is the more resilient| Metric | AVPT | CLBT |
|---|---|---|
| Beta | 0.73 | 0.69 |
| Sharpe ratio | 0.69 | -0.62 |
| Sortino ratio | 1.01 | -0.78 |
| Max drawdown | -36.3% | -45.9% |
| Current drawdown | -4.6% | -40.2% |
| Annualized volatility | 42.2% | 59.5% |
| Value at risk (95%) | -3.9% | -4.9% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AVPT or CLBT?
On the Algovestiq AIQ Score, AVPT is the stronger of the two as of Nov 15, 2026, scoring 70 against CLBT's 59. The edge comes from momentum and risk resilience. CLBT is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AVPT or CLBT the better buy right now?
AVPT carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the leader's advantage has been narrowing. Treat the lead as provisional.
Why does the AIQ Score favor AVPT over CLBT?
The composite weights Quality, Value, Momentum and Risk Resilience. AVPT leads Momentum by 37 points; AVPT leads Risk Resilience by 17 points; CLBT leads Value by 13 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AVPT or CLBT?
Analyst price targets imply +12.4% upside for AVPT and not covered for CLBT. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AVPT or CLBT?
CLBT is the better-valued of the two on the peer-relative Value factor. CLBT on the peer-relative Value factor, by 13 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AVPT or CLBT?
CLBT on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AVPT or CLBT?
AVPT on the Momentum factor, by 37 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AVPT or CLBT?
AVPT is the more resilient of the two, so the other name carries the higher downside risk. AVPT on Risk Resilience, by 17 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AVPT more profitable than CLBT?
CLBT leads on the comparable margin measures — gross margin 72.9% vs 82.3%; operating margin 10% vs 12%; ttm roe 4.1% vs 4.6%.
Is AVPT's lead over CLBT getting stronger or weaker?
AVPT lead: Weakening — the AIQ differential moved from 16 to 11 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-06-09, when AVPT moved ahead of CLBT.
What would change the AVPT vs CLBT verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CLBT closes the Momentum gap — currently 37 points behind, the largest single contributor to AVPT's edge; CLBT's Death Cross Active resolves — a bearish trend rule currently active against it; AVPT's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 5 points over 30 sessions, and a further 11-point move would eliminate AVPT's advantage entirely.
What do the current signals say about AVPT and CLBT?
AVPT: 3 bullish / 2 bearish / 1 neutral, conflicted. CLBT: 3 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVPT is Golden Cross Active (bullish, long horizon). On CLBT it is Death Cross Active (bearish, long horizon).
Compare AVPT and CLBT with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.